Rock Creek Group, LP Eiger Bio Pharmaceuticals, Inc. Transaction History

Rock Creek Group, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$7.98 - $12.29 $139,354 - $214,620	-17,463 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$7.96 - $12.42 $329,838 - $514,647	-41,437 Reduced 70.35%	17,463 $142,000
Q2 2020 Aug 13, 2020	BUY	$5.4 - $13.37 $138,780 - $343,609	25,700 Added 77.41%	58,900 $565,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $163,012 - $488,040	33,200 New	33,200 $226,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $527M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.